Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

MELATONINA NOXAREM 3 MG COMPRIMIDOS - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/MELATONINA NOXAREM 3 MG COMPRIMIDOS

Approved

STANDARD

MELATONINA NOXAREM 3 MG COMPRIMIDOS

Vemedia Manufacturing B.V.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: May 4, 2023
Approval ID: f78f0a61ea68ebbc
Company: Vemedia Manufacturing B.V.
Type: Standard

Approval Details

Approval Id: f78f0a61ea68ebbc
Drug Cima Aemps Name: MELATONINA NOXAREM 3 MG COMPRIMIDOS
Register Number: 88821
Holder Company Name: Vemedia Manufacturing B.V.
Marketing Company Name: Vemedia Pharma Hispania S.A.
Authorization Date: 2023-05-04
Dosage Form: COMPRIMIDO
Dose: 3 mg
Route Of Administration: VÍA ORAL
Prescription Type: Sin Receta
Commercialized: Yes
Company Name: Vemedia Manufacturing B.V.

Active Ingredients

MELATONINA

3 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

May 4, 2023

Approval ID

f78f0a61ea68ebbc

Type

Standard

Back to CIMA-AEMPS Approvals